Skip to content

UTTARA BASTI IN THE MANAGEMENT OF KLAIBYA (ED)

A CLINICAL STUDY ON THE EFFICACY OF UTTARA BASTI IN THE MANAGEMENT OF KLAIBYA W.S.R. TO ERECTILE DYSFUNCTION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037739
Enrollment
40
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N529- Male erectile dysfunction, unspecified

Interventions

None listed

Sponsors

Pt Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with signs and symptoms of Klaibya according the special scoring system for sexual parameters. 2 Patients those fit for Uttara Basti Karma. 3 Patientââ?¬•s BMI 4 Patients who have given written consent to participate in the study. 5 Standard operative procedure of COVID 19 pandemic will be adopted in all patients.

Exclusion criteria

Exclusion criteria: 1 Patientââ?¬•s age below 26 years and above 45 years. 2 Patients having other systemic pathology like Tuberculosis, Renal failure, Diabetes Mellitus, Hypertension, severe urinary tract infections, Nephrolithiasis, Urethral stricture and Medico Renal Diseases (MRD) or malignancy of urogenital system etc. 3 Patients having congenital deformity of urogenital tract. 4 Patientââ?¬•s BMI > 24.9 (Overweight). 5 Patients who are not willing to sign written consent to participate in the study. 6 Previous positive history or suspected patients of COVID 19 will be excluded.

Design outcomes

Primary

MeasureTime frame
It is expected that at the end of the study we would be able to demonstrate the effect of Uttara Basti in the management of Klaibya (ED). It is further expected that this study would be able to provide efficacy of Uttara Basti management of Klaibya (ED).Timepoint: 12 Months

Secondary

MeasureTime frame
It is expected that at the end of the study we would be able to provide Improvement in the semen analysis reports was considered to assess the total effect of the therapy.Timepoint: 11 Months

Countries

India

Contacts

Public ContactDr Mukesh Kumar sagar

Pt Khushilal Sharma Government (Autonomous) Ayurveda College and Institute (MP)

umeshayurvedabhopal@gmail.com9425373046

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026